Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists

被引:36
|
作者
Randall, Patrick A. [1 ]
Nunes, Eric J. [1 ]
Janniere, Simone L. [1 ]
Stopper, Colin M. [1 ]
Farrar, Andrew M. [1 ]
Sager, Thomas N. [2 ]
Baqi, Younis [3 ]
Hockemeyer, Joerg [3 ]
Mueller, Christa E. [3 ]
Salamone, John D. [1 ]
机构
[1] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA
[2] H Lundbeck & Co AS, Pharmacol Target Res, DK-2500 Copenhagen, Denmark
[3] Univ Bonn, Inst Pharmazeut, Pharma Zentrum Bonn, D-5300 Bonn, Germany
关键词
Activation; Anergia; Psychomotor slowing; Depression; Dopamine; Parkinsonism; SCHEDULE-CONTROLLED BEHAVIOR; D-AMPHETAMINE; RECEPTOR ANTAGONISTS; NUCLEUS-ACCUMBENS; SYMPATHOMIMETIC AMINES; LOCOMOTOR SUPPRESSION; DECISION-MAKING; MSX-3; REVERSES; CAFFEINE; DOPAMINE;
D O I
10.1007/s00213-011-2198-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Adenosine A(2A) antagonists can reverse many of the behavioral effects of dopamine antagonists, including actions on instrumental behavior. However, little is known about the effects of selective adenosine antagonists on operant behavior when these drugs are administered alone. The present studies were undertaken to investigate the potential for rate-dependent stimulant effects of both selective and nonselective adenosine antagonists. Six drugs were tested: two nonselective adenosine antagonists (caffeine and theophylline), two adenosine A(1) antagonists (DPCPX and CPT), and two adenosine A(2A) antagonists (istradefylline (KW6002) and MSX-3). Two schedules of reinforcement were employed; a fixed interval 240-s (FI-240 sec) schedule was used to generate low baseline rates of responding and a fixed ratio 20 (FR20) schedule generated high rates. Caffeine and theophylline produced rate-dependent effects on lever pressing, increasing responding on the FI-240 sec schedule but decreasing responding on the FR20 schedule. The A(2A) antagonists MSX-3 and istradefylline increased FI-240 sec lever pressing but did not suppress FR20 lever pressing in the dose range tested. In fact, there was a tendency for istradefylline to increase FR20 responding at a moderate dose. A(1) antagonists failed to increase lever pressing rate, but DPCPX decreased FR20 responding at higher doses. These results suggest that adenosine A(2A) antagonists enhance operant response rates, but A(1) antagonists do not. The involvement of adenosine A(2A) receptors in regulating aspects of instrumental response output and behavioral activation may have implications for the treatment of effort-related psychiatric dysfunctions, such as psychomotor slowing and anergia in depression.
引用
收藏
页码:173 / 186
页数:14
相关论文
共 50 条
  • [1] Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists
    Patrick A. Randall
    Eric J. Nunes
    Simone L. Janniere
    Colin M. Stopper
    Andrew M. Farrar
    Thomas N. Sager
    Younis Baqi
    Jörg Hockemeyer
    Christa E. Müller
    John D. Salamone
    Psychopharmacology, 2011, 216 : 173 - 186
  • [2] Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism
    Salamone, John D.
    Farrar, Andrew M.
    Font, Laura
    Patel, Vatsal
    Schlar, Devra E.
    Nunes, Eric J.
    Collins, Lyndsey E.
    Sager, Thomas N.
    BEHAVIOURAL BRAIN RESEARCH, 2009, 201 (01) : 216 - 222
  • [3] Optimization of arylindenopyrimidines as potent adenosine A2A/A1 antagonists
    Shook, Brian C.
    Rassnick, Stefanie
    Chakravarty, Devraj
    Wallace, Nathaniel
    Ault, Mark
    Crooke, Jeffrey
    Barbay, J. Kent
    Wang, Aihua
    Leonard, Kristi
    Powell, Mark T.
    Alford, Vernon
    Hall, Daniel
    Rupert, Kenneth C.
    Heintzelman, Geoffrey R.
    Hansen, Kristen
    Bullington, James L.
    Scannevin, Robert H.
    Carroll, Karen
    Lampron, Lisa
    Westover, Lori
    Russell, Ronald
    Branum, Shawn
    Wells, Kenneth
    Damon, Sandra
    Youells, Scott
    Beauchamp, Derek
    Li, Xun
    Rhodes, Kenneth
    Jackson, Paul F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2868 - 2871
  • [4] Methylene amine substituted arylindenopyrimidines as potent adenosine A2A/A1 antagonists
    Shook, Brian C.
    Rassnick, Stefanie
    Hall, Daniel
    Rupert, Kenneth C.
    Heintzelman, Geoffrey R.
    Hansen, Kristen
    Chakravarty, Devraj
    Bullington, James L.
    Scannevin, Robert H.
    Magliaro, Brian
    Westover, Lori
    Carroll, Karen
    Lampron, Lisa
    Russell, Ronald
    Branum, Shawn
    Wells, Kenneth
    Damon, Sandra
    Youells, Scott
    Li, Xun
    Osbourne, Mel
    Demarest, Keith
    Tang, Yuting
    Rhodes, Kenneth
    Jackson, Paul F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) : 2864 - 2867
  • [5] Tremorolytic effects of adenosine A2A antagonists:: implications for parkinsonism
    Salamone, John D.
    Betz, Adrienne J.
    Ishiwari, Keita
    Felsted, Jennifer
    Madson, Lisa
    Mirante, Brian
    Clark, Karen
    Font, Laura
    Korbey, Samantha
    Sager, Thomas N.
    Hockemeyer, Jorg
    Muller, Christa E.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 3594 - 3605
  • [6] Design and Characterization of Optimized Adenosine A2A/A1 Receptor Antagonists for the Treatment of Parkinson's Disease
    Shook, Brian C.
    Rassnick, Stefanie
    Wallace, Nathaniel
    Crooke, Jeffrey
    Ault, Mark
    Chakravarty, Devraj
    Barbay, J. Kent
    Wang, Aihua
    Powell, Mark T.
    Leonard, Kristi
    Alford, Vernon
    Scannevin, Robert H.
    Carroll, Karen
    Lampron, Lisa
    Westover, Lori
    Lim, Heng-Keang
    Russell, Ronald
    Branum, Shawn
    Wells, Kenneth M.
    Damon, Sandra
    Youells, Scott
    Li, Xun
    Beauchamp, Derek A.
    Rhodes, Kenneth
    Jackson, Paul F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) : 1402 - 1417
  • [7] New adenosine A2A receptor antagonists:: Actions on Parkinson's disease models
    Pinna, A
    Volpini, R
    Cristalli, G
    Morelli, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 512 (2-3) : 157 - 164
  • [8] Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
    Marcoli, M
    Raiteri, L
    Bonfanti, A
    Monopoli, A
    Ongini, E
    Raiteri, M
    Maura, G
    NEUROPHARMACOLOGY, 2003, 45 (02) : 201 - 210
  • [9] Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX
    Collins, Lyndsey E.
    Galtieri, Daniel J.
    Brennum, Lise T.
    Sager, Thomas N.
    Hockemeyer, Joerg
    Mueller, Christa E.
    Hinman, James R.
    Chrobak, James J.
    Salamone, John D.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 94 (04) : 561 - 569
  • [10] Effects of adenosine A2A receptor antagonists on cocaine-induced locomotion and cocaine seeking
    Haynes, Nicholas S.
    O'Neill, Casey E.
    Hobson, Benjamin D.
    Bachtell, Ryan K.
    PSYCHOPHARMACOLOGY, 2019, 236 (02) : 699 - 708